
Sign up to save your podcasts
Or
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
4.5
2828 ratings
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
26 Listeners
493 Listeners
185 Listeners
3 Listeners
7,928 Listeners
755 Listeners
12 Listeners
51 Listeners
52 Listeners
133 Listeners
1 Listeners
169 Listeners
48 Listeners
39 Listeners
3 Listeners